Exploring Health-Related Quality of Life Burden in Peanut Allergy and the Potential Benefit of Oral Immunotherapy: Estimation of Health State Utility Values for Children and Adolescents and Their Caregivers-Reference-Cited by-同舟云学术

Exploring Health-Related Quality of Life Burden in Peanut Allergy and the Potential Benefit of Oral Immunotherapy: Estimation of Health State Utility Values for Children and Adolescents and Their Caregivers

Published:2022-05 Issue: Volume:Volume 16 Page:1269-1278
ISSN:1177-889X
Container-title:Patient Preference and Adherence
language:en
Short-container-title:PPA

Author:

Gallop Katy^ORCID,Acaster Sarah,de Vries Jane,Browne Richard,Ryan Robert^ORCID,Baker Sarah,Du Toit George

Publisher

Informa UK Limited

Subject

Health Policy,Pharmacology, Toxicology and Pharmaceutics (miscellaneous),Social Sciences (miscellaneous),Medicine (miscellaneous)

Reference25 articles.

1. Evaluation of the epidemiology of peanut allergy in the United Kingdom

2. Fatalities due to anaphylactic reactions to foods

3. Peanut allergy: Burden of illness

4. APPEAL‐2: A pan‐European qualitative study to explore the burden of peanut‐allergic children, teenagers and their caregivers

5. Impact of peanut allergy on quality of life, stress and anxiety in the family

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Estimating the Health-Related Quality of Life Benefit of Prophylactic Treatment for COVID-19 in Immunocompromised People: A Multimethod Valuation Study;Journal of Health Economics and Outcomes Research;2024-07-24

2. Estimating the Health-Related Quality of Life Benefit of Prophylactic Treatment for COVID-19 in Immunocompromised People: A Multimethod Valuation Study;Journal of Health Economics and Outcomes Research;2024-07-24

3. BSACI guidance for the implementation of Palforzia® peanut oral immunotherapy in the United Kingdom: A Delphi consensus study;Clinical & Experimental Allergy;2024-06-26